---
title: "300267.SZ (300267.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300267.SZ/news.md"
symbol: "300267.SZ"
name: "300267.SZ"
parent: "https://longbridge.com/en/quote/300267.SZ.md"
datetime: "2026-05-20T20:35:37.280Z"
locales:
  - [en](https://longbridge.com/en/quote/300267.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300267.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300267.SZ/news.md)
---

# 300267.SZ (300267.SZ) — Related News

### [](https://longbridge.com/en/news/284158551.md)
*2026-04-27T05:54:07.000Z*
> A-share pharmaceutical stocks showed volatile strength; Guangji Pharma hit the limit-up in the afternoon, while Fushine,

### [Healthcare Industry Daily (04.23): Breakthroughs in Pharmaceutical Innovation](https://longbridge.com/en/news/283880811.md)
*2026-04-23T19:16:18.000Z*
> Hengrui Pharma's revenue in the first quarter of 2026 was 8.141 billion yuan, with a net profit attributable to the pare

### [ER-KANG released its first-quarter performance, with a net profit attributable to the parent company of 13.1086 million yuan, a decrease of 53.37%](https://longbridge.com/en/news/283857867.md)
*2026-04-23T15:01:27.000Z*
> ER-KANG released its first quarter report for 2026, with operating revenue of 247 million yuan, a year-on-year decrease 

### [ER-KANG: Net loss of 380 million yuan in 2025](https://longbridge.com/en/news/283637052.md)
*2026-04-22T09:48:32.000Z*
> ER-KANG announced that the operating revenue in 2025 is expected to be 1.166 billion yuan, a year-on-year increase of 2.

### [ER-KANG: Agreed to use self-raised funds of USD 13 million to invest in the construction of a comprehensive processing project for various metal minerals](https://longbridge.com/en/news/283637042.md)
*2026-04-22T09:48:23.000Z*
> ER-KANG announced that the company will hold the third meeting of the sixth board of directors on April 22, 2026, to rev

### [Pharmaceutical stocks surged against the market trend! On September 20, 2023, a "30cm" limit up!](https://longbridge.com/en/news/281465073.md)
*2026-04-02T04:31:25.000Z*
> In today's early trading, the A-shares overall weakened. Driven by a collective surge in pharmaceutical stocks, the Nort

### [ER-KANG's controlling shareholder Shuai Fangwen plans to reduce his holdings by no more than 2.04%](https://longbridge.com/en/news/281171385.md)
*2026-03-31T10:42:04.000Z*
> ER-KANG's controlling shareholder Shuai Fangwen plans to reduce his holdings by no more than 42 million shares, accounti

### [Zimbabwe bans lithium ore exports! Lithium concept stocks surge, ER-KANG hits 20% limit up, strategic metal supply disruptions become increasingly frequent](https://longbridge.com/en/news/276969069.md)
*2026-02-26T01:57:17.000Z*
> Zimbabwe announces a suspension of lithium concentrate and raw ore exports, leading to a surge in lithium concept stocks

### [ER-KANG expects a net loss attributable to the parent company of RMB 325 million to RMB 385 million for the fiscal year 2025](https://longbridge.com/en/news/274142180.md)
*2026-01-29T11:40:04.000Z*
> ER-KANG expects a net loss attributable to shareholders for the fiscal year 2025 to be between 325 million yuan and 385